Free morning briefing · 07:30 weekdays
The RNS that moves prices, in your inbox before the open.
AI-ranked movers and high-impact RNS across the FTSE 100, 250, SmallCap and AIM — one short email, every market day.
Get the briefing
HVO

hVIVO plc

HVOLSEUnited KingdomHealthcareDiagnostics & ResearchAIM

hVIVO plc operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America. It provides end-to-end early clinical development services to the biopharmaceutical industry, including phase I capabilities and world leading human challenge trial…more

P/B1.24xROIC-6.4%Dividend yield2.7%
£40.05M
Market Cap
EV: £40.84M
MOM5
QUAL1
VAL6
RSK6
HVO
£40.05M
Market Cap · EV £40.84M

hVIVO plc

MOM5
QUAL1
VAL6
RSK6

hVIVO plc operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America. It provides end-to-end early clinical development services to the biopharmaceutical industry, including phase I capabilities and world leading human challenge trial…more

Latest RNS from hVIVO plc

All HVO news → · RNS daily feed

Analyst consensus: Buy

As of 22 Oct 2026, 7 analysts rate hVIVO plc a Buy, with 71% buy ratings and a mean price target of 16p (range 10p–25p), +163% vs the current price.

Strong buy: 0Buy: 5Hold: 2Sell: 0Strong sell: 0

Full analyst history →

More Healthcare companies